CJC-1295 in Háj u Duchcova — GHRH Analog Research Guide
CJC-1295 research guide for Háj u Duchcova. Covers DAC vs no-DAC forms, half-life differences, purity testing, and how to source quality CJC-1295 for research.
For anyone in Háj u Duchcova searching for CJC-1295, the first thing to know is that this compound is available only through an online research supply market. What this means for Háj u Duchcova researchers is that geography is secondary to your ability to evaluate vendor quality — and those verification methods are within reach of all serious researchers. Separating properly characterised CJC-1295 from the rest of the market depends on three things: an HPLC chromatogram documenting ≥98% purity, mass spec data verifying the correct molecular weight, and a batch-specific endotoxin panel. This guide gives Háj u Duchcova researchers the framework to verify sourcing options methodically and source research-grade CJC-1295 with confidence.
CJC-1295: What the Research Shows
CJC-1295 with DAC (Drug Affinity Complex) is a GHRH analogue with an extended half-life achieved through DAC technology that enables covalent binding to albumin. This modification extends the half-life from minutes (for native GHRH) to approximately 6-8 days, creating a sustained elevation in basal GH levels rather than the pulsatile pattern produced by GHRP compounds. This pharmacokinetic distinction is significant for research design: CJC-1295 based on CJC-1295 with DAC produces a different GH secretion pattern than GHRP compounds, with different downstream effects on IGF-1 and protein synthesis. Researchers in Háj u Duchcova comparing compounds in this class should account for these pharmacokinetic differences in their experimental design.
Sourcing Research-Grade CJC-1295
Vetting CJC-1295 vendors begins with the COA: access the batch-specific certificate before purchasing, not after. Mass spectrometry in the COA establishes that the main HPLC peak is actually CJC-1295 and not another compound with similar chromatographic behaviour — HPLC purity alone cannot verify molecular identity. Warning signs in CJC-1295 vendor evaluation: prices far under typical market pricing, unclear production details, no community presence, and COAs that lack endotoxin data. For Háj u Duchcova researchers making a first CJC-1295 purchase: work through this evaluation framework first, begin with a small order, and verify batch traceability on arrival before use.
Order CJC-1295 — ships to Háj u Duchcova
COA-verified · International tracking · Research grade
All use of CJC-1295 in Háj u Duchcova or anywhere is research use only — this compound is not approved for human therapeutic use, and all handling should follow research laboratory protocols. Reconstitute CJC-1295 with bacteriostatic water at a concentration matched to your dosing requirements; a standard 5mg in 2mL gives a 2.5mg/mL solution — providing 25mcg per unit measured on a 100-unit syringe. Endotoxin testing in the CJC-1295 COA is absolutely required — gram-negative bacterial endotoxins can trigger serious inflammatory reactions at very low concentrations, and no cost saving makes omitting this acceptable. For any individual considering CJC-1295 outside a formal research context: seek medical advice first — this compound is unapproved for human therapeutic application and its risk profile is not equivalent to approved medications.
Frequently Asked Questions
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.
What is CJC-1295?
CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.
What purity is required for CJC-1295 research?
CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.
